Cargando…
Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury
Chondroitinase ABC is a promising preclinical therapy that promotes functional neuroplasticity after CNS injury by degrading extracellular matrix inhibitors. Efficient delivery of chondroitinase ABC to the injured mammalian spinal cord can be achieved by viral vector transgene delivery. This approac...
Autores principales: | Burnside, Emily R, De Winter, Fred, Didangelos, Athanasios, James, Nicholas D, Andreica, Elena-Cristina, Layard-Horsfall, Hugo, Muir, Elizabeth M, Verhaagen, Joost, Bradbury, Elizabeth J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061881/ https://www.ncbi.nlm.nih.gov/pubmed/29912283 http://dx.doi.org/10.1093/brain/awy158 |
Ejemplares similares
-
Chondroitinase gene therapy improves upper limb function following cervical contusion injury
por: James, Nicholas D., et al.
Publicado: (2015) -
Combined treatment with enteric neural stem cells and chondroitinase ABC reduces spinal cord lesion pathology
por: Jevans, Benjamin, et al.
Publicado: (2021) -
Secretion of a mammalian chondroitinase ABC aids glial integration at PNS/CNS boundaries
por: Warren, Philippa M., et al.
Publicado: (2020) -
Chronic muscle recordings reveal recovery of forelimb function in spinal injured female rats after cortical epidural stimulation combined with rehabilitation and chondroitinase ABC
por: Sinopoulou, Eleni, et al.
Publicado: (2022) -
Combined Transcriptomics, Proteomics and Bioinformatics Identify Drug Targets in Spinal Cord Injury
por: Tica, Jure, et al.
Publicado: (2018)